Sepsis-3
Showing 1 - 25 of >10,000
Sepsis-3 Study in Northeast Thailand
Recruiting
- Sepsis
- Community-Acquired Infections
- Specimens collection
-
Ubon Ratchathani, ThailandSappasithiprasong Hospital
Aug 1, 2022
HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis
Not yet recruiting
- Sepsis
- nothing
-
Tianjin, Tianjin, ChinaTianjin Nankai Hospital
Sep 13, 2023
Practical Cinical UTility of NuQ.® H3.1 Nucleosome Levels in
Not yet recruiting
- Sepsis
- NuQ H3.1 Nucleosome Assay
-
London, United KingdomGuy's & St Thomas' NHS Foundation Trust
Jun 19, 2023
Circulatory Shock and Sepsis (MiMICSS)
Recruiting
- Sepsis
- +2 more
- Skeletal muscle and cerebral NIRS (research device)
-
Winnipeg, Manitoba, CanadaHealth Sciences Centre Winnipeg
Aug 2, 2023
INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in
Recruiting
- Sepsis
- Blood collection
-
Toulouse, FranceUniversity Hospital of Toulouse
Jun 8, 2022
Sepsis, ARDS, Critical Illness Trial in London (Phelebotomy, Broncheoalveolar Lavage)
Not yet recruiting
- Sepsis
- +8 more
- Phelebotomy
- Broncheoalveolar Lavage
-
London, Ontario, CanadaAleks Leligdowicz
Oct 25, 2022
CRP and PCT as Predictors of Sepsis Cause
Not yet recruiting
- Sepsis
- +2 more
- PCT levels
- +3 more
-
Osijek, CroatiaUniversity Hospital Osijek
Oct 30, 2022
Neonatal Sepsis Trial in Worldwide (Ceftobiprole medocaril)
Recruiting
- Neonatal Sepsis
- Ceftobiprole medocaril
-
Los Angeles, California
- +14 more
May 3, 2023
NGS-Based Assay of Blood Samples of Sepsis Rapid Bacterial
Recruiting
- Pneumonia
- +3 more
- NGS-based assay for bacterial identification
-
Chaïdári, Attiki, Greece
- +3 more
Nov 21, 2023
Sepsis Trial in United Kingdom (Prevenar 13, Sodium Chloride 0.9%)
Active, not recruiting
- Sepsis
- Prevenar 13
- Sodium Chloride 0.9%
-
Belfast, United Kingdom
- +11 more
Dec 12, 2022
Sepsis Trial in Cairo (Vitamin D3 tablets, Vitamin D tablets)
Recruiting
- Sepsis
- Vitamin D3 tablets
- Vitamin D tablets
-
Cairo, EgyptAin-Shams University Hospitals
Apr 13, 2022
Postpartum Sepsis, Postpartum Endometritis, Postpartum Fever Trial in Bamenda (Azithromycin, Azithromycin and amoxicillin,
Completed
- Postpartum Sepsis
- +2 more
- Azithromycin
- +2 more
-
Bamenda, CameroonCameroon Baptist Convention Health Services
Mar 18, 2022
Sidestream Dark-Field Imaging of Intestinal Microcirculation
Active, not recruiting
- Sepsis
-
Halifax, Nova Scotia, CanadaQueen Elizabeth II Health Sciences Cetnre
Mar 7, 2022
Septic Shock Trial in Calgary (Therapeutic plasma exchange)
Recruiting
- Septic Shock
- Therapeutic plasma exchange
-
Calgary, Alberta, Canada
- +1 more
Feb 15, 2022
Acute Kidney Injury, Sepsis Trial in Foshan (Standard Reagents, Whole Blood)
Recruiting
- Acute Kidney Injury
- Sepsis
- Standard Reagents, Whole Blood
-
Foshan, ChinaCritical Care Department, First People's Hospital of Foshan
Jan 19, 2023
Septic Shock, Vasodilatory Shock Trial in Albuquerque (Angiotensin II)
Recruiting
- Septic Shock
- Vasodilatory Shock
- Angiotensin II
-
Albuquerque, New MexicoUniversity of New Mexico Health Sciences Center
Apr 19, 2023
Severe Intra-abdominal Sepsis Managed With Laparostomy and
Completed
- Abdominal Sepsis
-
Thessaloniki, Greece3rd Department of Surgery, AHEPA University Hospital
Aug 25, 2021
Children After Hospitalization in Intensive Care Unit
Not yet recruiting
- Renal Disease
- +7 more
- neurocognitive tests
-
Calgary, Alberta, Canada
- +7 more
Nov 3, 2023
Sepsis, Sepsis-induced Coagulopathy, Nafamostat Mesilate Trial (Nafamostat mesilate, 5% glucose)
Not yet recruiting
- Sepsis
- +2 more
- Nafamostat mesilate
- 5% glucose
- (no location specified)
Oct 5, 2023
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +3 more
- Ertapenem
- Placebo
-
Montreal, Quebec, CanadaMcGill University Health Centre (Royal Victoria Hospital and Mon
Feb 21, 2022
CLABSI - Central Line Associated Bloodstream Infection Trial in Baltimore (Sodium Citrate 4% Inj Syringe 3Ml)
Recruiting
- CLABSI - Central Line Associated Bloodstream Infection
- Sodium Citrate 4% Inj Syringe 3Ml
-
Baltimore, MarylandJohns Hopkins
Oct 12, 2022
Sepsis, Severe Sepsis, End Organ Damage Trial in Boston (vitamin D3, Placebo)
Withdrawn
- Sepsis
- +3 more
- vitamin D3
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Apr 30, 2021
Multi-Drug Resistant Organisms, Late-Onset Sepsis, Neonatal, Antimicrobial Resistance Trial in Edmonton (Exposure of interest)
Recruiting
- Multi-Drug Resistant Organisms
- +2 more
- Exposure of interest
-
Edmonton, Alberta, CanadaRoyal Alexandra Hospital
Dec 7, 2021
Gastroenteritis, Bronchiolitis, Sepsis Trial in Montreal (0.9% saline in 5% dextrose (intravenous), 0.45% saline in 5% dextrose
Completed
- Gastroenteritis
- +3 more
- 0.9% saline in 5% dextrose (intravenous)
- 0.45% saline in 5% dextrose (intravenous)
-
Montreal, Quebec, CanadaMontreal Children's Hospital
Apr 4, 2022
Sepsis Trial in Worldwide (Anakinra or rhIFN?, Placebo)
Recruiting
- Sepsis
- Anakinra or rhIFNγ
- Placebo
-
Jena, Germany
- +25 more
Jul 13, 2022